Results 291 to 300 of about 94,040 (310)

[Change of ESBLs-KPN and ESBLs-ECO after antimicrobial intervention].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2010
To evaluate the change of extended spectrum beta-lactamase (ESBLs) Producing Klebsiella Pneumoniae (ESBLs-KPN) and Escherichia coli (ESBLs-ECO) causing nosocomial infection after antimicrobial intervention.We regularly monitored the data on the yearly consumption [defined as daily dose (DDD) per 1 000 patient-days] of frequently used antibiotics from ...
Yu Yang, Wei Cao, Yawen Gao, Yuetao Wu, Qiwei Zhou   +4 more
openaire   +3 more sources

Extended-Spectrum-Betalaktamasen (ESBL): gestern ESBL – heute ESBL, Carbapenemase-Bildner und multiresistente Bakterien

DMW - Deutsche Medizinische Wochenschrift, 2012
Extended-spectrum beta-lactamases (ESBLs), which confer resistance to third generation cephalosporins, demonstrate how rapidly resistance mechanisms can evolve. These enzymes were discovered in few isolates in the late 1980s. They have now reached significant levels in hospitals and the community worldwide. Different ESBL enzyme variants (TEM, SHV, CTX-
openaire   +3 more sources

Characterization of ESBL disseminating plasmids

Infectious Diseases, 2015
Bacteria producing extended-spectrum β-lactamases (ESBLs) constitute a globally increasing problem that contributes to treatment complications and elevated death rates. The extremely successful dissemination by ESBL-producing Enterobacteriaceae during the latest decades is a result of the combination of mobilization, evolution and horizontal spread of ...
Linus Sandegren, Alma Brolund
openaire   +2 more sources

Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen

Journal of Clinical Microbiology, 1996
Resistance to contemporary broad-spectrum beta-lactams, mediated by extended-spectrum beta-lactamase (ESBL) enzymes, is an increasing problem worldwide. The Etest (AB Biodisk, Solna, Sweden) ESBL screen uses stable gradient technology to evaluate the MIC of ceftazidime alone compared with the MIC of ceftazidime with clavulanic acid (2 micrograms/ml) to
Martin Cormican, R N Jones, Steven A. Marshall   +2 more
openaire   +2 more sources

ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome

Infection control and hospital epidemiology, 2019
Objective: To determine whether colonization with extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) predicts the risk for subsequent infection and impacts carbapenem-consumption and outcome in intensive care unit (ICU) patients. Design:
A. Martinez, A. Widmer, R. Frei, H. Pargger, D. Tuchscherer, S. Marsch, A. Egli, S. Tschudin-Sutter   +7 more
semanticscholar   +1 more source

Cefepime pharmacodynamics in patients with extended spectrum β-lactamase (ESBL) and non-ESBL infections

Journal of Infection, 2007
This study was designed to compare cefepime exposures with microbiological outcomes in ESBL and non-ESBL infections and determine the pharmacodynamic profiles associated with successful outcome.Cefepime pharmacodynamic exposures of unbound drug [time above MIC (fT>MIC), minimal concentration over MIC (fC(min)/MIC), and area under the curve over MIC ...
Joseph L. Kuti, David P. Nicolau, Su Young Lee   +2 more
openaire   +3 more sources

Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.

Journal of Antimicrobial Chemotherapy, 2019
BACKGROUND The population structure of extraintestinal pathogenic Escherichia coli evolves over time, notably due to the emergence of antibiotic-resistant clones such as ESBL-producing Enterobacteriaceae (ESBL-E).
A. Birgy, F. Madhi, C. Jung, C. Levy, A. Cointe, P. Bidet, C. Hobson, S. Béchet, E. Sobral, H. Vuthien, A. Ferroni, S. Aberrane, G. Cuzon, L. Beraud, V. Gajdos, E. Launay, D. Pinquier, H. Haas, M. Desmarest, M. Dommergues, R. Cohen, S. Bonacorsi   +21 more
semanticscholar   +1 more source

Patiënt met ESBL

2017
Geachte mevrouw Abraham-Inpijn, u hebt aangeboden dat wij per mail vragen mogen stellen. Ik wil heel graag op uw aanbod terugkomen. Ik heb een patient in een verpleegkliniek. Hij komt min of meer regelmatig naar mijn praktijk voor onder andere gebitsreiniging.
openaire   +2 more sources

Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe

Journal of Antimicrobial Chemotherapy, 2018
Background The ST131 Escherichia coli clone is associated with the global dissemination of ESBLs. It has been hypothesized that ST131 could take advantage of better colonizing abilities.
I. Merino, M. Hernández-García, M. Turrientes, B. Pérez-Viso, N. López-Fresneña, C. Díaz-Agero, F. Maechler, Carolina Fankhauser-Rodriguez, A. Kola, J. Schrenzel, S. Harbarth, M. Bonten, P. Gastmeier, R. Cantón, P. Ruiz-Garbajosa, Marc Desilets, Stéphanie Dul, Fabienne Scherrer-Muller, B. Huttner, I. Uçkay, V. Prendki, G. Renzi   +21 more
semanticscholar   +1 more source